NCT02908295View on ClinicalTrials.gov

Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss: A Randomized Placebo-controlled Study

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

April 30, 2018

Conditions
Misoprostol, Blood Loss, Myomectomy
Interventions
DRUG

Rectal Misoprostol

Rectal Misoprostol Misoprostol 400 mcg (200 mcg/tablet) or 2 tablets were given rectally at 15 - 30 minutes prior the operation

DRUG

Placebo

Rectal Vitamin B6 Vitamin B6 (Placebo) 200 mg (100 mg/tablet) or 2 tablets were given rectally at 15 - 30 minutes prior the operation

Trial Locations (1)

10400

Rajavithi hospital, Bangkok

All Listed Sponsors
lead

Department of Medical Services Ministry of Public Health of Thailand

OTHER_GOV

NCT02908295 - Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss: A Randomized Placebo-controlled Study | Biotech Hunter | Biotech Hunter